{
    "nct_id": "NCT05412953",
    "official_title": "Tonation Breathing Technique, a Non-Pharmacogenic Method to Ease Aromatase Inhibitor-Induced Musculoskeletal Symptoms - A Pilot Study",
    "inclusion_criteria": "* Females with stage I-III breast cancer taking adjuvant aromatase inhibitor (AI) (either standard dose of anastrozole 1 mg daily or letrozole 2.5 mg daily or exemestane 25 mg daily) for greater than 30 days experiencing AI induced musculoskeletal pain scores of 5 or higher on a Likert scale will be enrolled\n* Subjects should have completed any planned surgery for breast cancer, chemotherapy and radiation therapy at least 30 days prior to enrollment\n* Patients should have an Eastern Cooperative Oncology Group (ECOG) performance score of 0-2\n* Patients should be at least 18 years old with no maximum age limit\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients should not have significant underlying pulmonary disease",
    "miscellaneous_criteria": ""
}